Pharmacoeconomic Analysis Of Afatinib As 1st-Line Treatment Of Metastatic Non-Small Cell Lung Cancer With Del19 Mutation Of Egfr Gene

Autor:	S Orlov, D Belousov, V Gorbunova, E.V. Afanasieva
Rok vydání:	2015
Předmět:	Oncology medicine.medical_specialty business.industry Afatinib Health Policy Public Health Environmental and Occupational Health medicine.disease Text mining Internal medicine Mutation (genetic algorithm) medicine Non small cell Line (text file) Lung cancer business Gene medicine.drug
Zdroj:	Value in Health. 18(7):A458-A459
ISSN:	1098-3015
DOI:	10.1016/j.jval.2015.09.1180
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd797834c6d8d3d92788bfeb055cd8d Zobrazit plný text záznamu Full Text from ScienceDirect